Assessing the Malaysian Regulatory Process for Medicinal Product Approval: An OpERA Methodology and Standardized Reporting Approach
- DOI
- 10.1007/s43441-025-00846-3
- Published
- 2025-07-25
- Container
- Therapeutic Innovation & Regulatory Science
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1007/s43441-025-00846-3,
title = {Assessing the Malaysian Regulatory Process for Medicinal Product Approval: An OpERA Methodology and Standardized Reporting Approach},
author = {Noraisyah Mohd Sani and Siti Hidayah Kasbon and Kian Yee Yap and Muhamad Firdaus Abdullah and Rosliza Lajis and Azuana Ramli and Neil McAuslane and Magda Bujar and Adem Kermad},
year = {2025},
journal = {Therapeutic Innovation \& Regulatory Science},
doi = {10.1007/s43441-025-00846-3},
url = {https://doi.org/10.1007/s43441-025-00846-3}
}RIS
TY - JOUR TI - Assessing the Malaysian Regulatory Process for Medicinal Product Approval: An OpERA Methodology and Standardized Reporting Approach AU - Noraisyah Mohd Sani AU - Siti Hidayah Kasbon AU - Kian Yee Yap AU - Muhamad Firdaus Abdullah AU - Rosliza Lajis AU - Azuana Ramli AU - Neil McAuslane AU - Magda Bujar AU - Adem Kermad PY - 2025 JO - Therapeutic Innovation & Regulatory Science DO - 10.1007/s43441-025-00846-3 UR - https://doi.org/10.1007/s43441-025-00846-3 ER -
APA
Sani, N. M., Kasbon, S. H., Yap, K. Y., Abdullah, M. F., Lajis, R., Ramli, A., McAuslane, N., Bujar, M., & Kermad, A. (2025). Assessing the Malaysian Regulatory Process for Medicinal Product Approval: An OpERA Methodology and Standardized Reporting Approach. Therapeutic Innovation & Regulatory Science. https://doi.org/10.1007/s43441-025-00846-3
Source records
- crossref · retrieved 2026-09-27T02:01:41.570Z